BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Bree E, Rovers KP, Stamatiou D, Souglakos J, Michelakis D, de Hingh IH. The evolving management of small bowel adenocarcinoma. Acta Oncologica 2018;57:712-22. [DOI: 10.1080/0284186x.2018.1433321] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Mohan H, Coffey J. Potential roles of the mesentery in Crohn's disease. Seminars in Colon and Rectal Surgery 2020;31:100743. [DOI: 10.1016/j.scrs.2020.100743] [Reference Citation Analysis]
2 Thiessen M, Lee-Ying RM, Monzon JG, Tang PA. An Examination of Lymph Node Sampling as a Predictor of Survival in Resected Node-Negative Small Bowel Adenocarcinoma: a SEER Database Analysis. J Gastrointest Cancer 2020;51:280-8. [PMID: 31111426 DOI: 10.1007/s12029-019-00250-9] [Reference Citation Analysis]
3 Azizi AH, Inam ZS, Farrell TJ. Patient with Lynch syndrome with subsequent development of small bowel adenocarcinoma. BMJ Case Rep 2018;2018:bcr-2018-225003. [PMID: 29866690 DOI: 10.1136/bcr-2018-225003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Zhen Y, Li J, Wang R, Lu S, Zhou Y, Xiao R. Metachronous small bowel adenocarcinoma after rectal adenocarcinoma: A case report. Medicine (Baltimore) 2021;100:e27448. [PMID: 34622864 DOI: 10.1097/MD.0000000000027448] [Reference Citation Analysis]
5 Gelsomino F, Balsano R, De Lorenzo S, Garajová I. Small Bowel Adenocarcinoma: From Molecular Insights to Clinical Management. Current Oncology 2022;29:1223-36. [DOI: 10.3390/curroncol29020104] [Reference Citation Analysis]
6 Dai ZH, Wang QW, Zhang QW, Yan XL, Aparicio T, Zhou YY, Wang H, Zhang CH, Zaanan A, Afchain P, Zhang Y, Chen HM, Gao YJ, Ge ZZ. Personalized four-category staging for predicting prognosis in patients with small bowel Adenocarcinoma: an international development and validation study. EBioMedicine 2020;60:102979. [PMID: 32980692 DOI: 10.1016/j.ebiom.2020.102979] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Zhou YY, Du XJ, Zhang CH, Aparicio T, Zaanan A, Afchain P, Chen LP, Hu SK, Zhang PC, Wu M, Zhang QW, Wang H. Comparison of three lymph node staging schemes for predicting the outcome in patients with small bowel adenocarcinoma: A population-based cohort and international multicentre cohort study. EBioMedicine 2019;41:276-85. [PMID: 30824384 DOI: 10.1016/j.ebiom.2019.02.043] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
8 Lu YM, Cheng P, Zhang LL. Clinical characteristics of primary small bowel adenocarcinoma. Shijie Huaren Xiaohua Zazhi 2019; 27(4): 282-286 [DOI: 10.11569/wcjd.v27.i4.282] [Reference Citation Analysis]
9 Fields AC, Lu PW, Li GZ, Welten V, Jolissaint JS, Vierra BM, Saadat LV, Larson AC, Atkinson RB, Melnitchouk N. Current practices and future steps for hyperthermic intraperitoneal chemotherapy. Curr Probl Surg 2020;57:100727. [PMID: 32151327 DOI: 10.1016/j.cpsurg.2019.100727] [Reference Citation Analysis]
10 Kauff DW, Babic B, Grimminger PP, Kneist W, Lang H. [Lymphadenectomy in oncological visceral surgery-Part 2 : Cancer of the upper and lower intestinal tract]. Chirurg 2019;90:505-21. [PMID: 31119337 DOI: 10.1007/s00104-019-0963-8] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]